Home / Features / Pfizer Inc. (NYSE:PFE) Won Authorization With Novartis For Two Cancer Drugs on Britain’s NHS- Harmonic Inc. (NASDAQ:HLIT)

Pfizer Inc. (NYSE:PFE) Won Authorization With Novartis For Two Cancer Drugs on Britain’s NHS- Harmonic Inc. (NASDAQ:HLIT)

Pfizer Inc. (NYSE:PFE) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it 7.07% to close at $32.12 with the total traded volume of 118.7 Million shares. Novartis and Pfizer (PFE) have won authorization for two cancer drugs to be used routinely on Britain’s National Health Service following offering bigger price discounts. The National Institute for Health and Care Excellence (NICE) stated on Thursday its draft guidance now recommended Novartis’ Afinitor for certain breast cancer patients and Pfizer’s Xalkori in lung cancer following the unrevealed “larger” discounts.

The move comes as NICE reappraises all drugs covered by the Cancer Drugs Fund, which was overhauled earlier this year. Japan’s Eisai last week won a same green light for its breast cancer drug Halaven following cutting the price for Britain’s state health service. The firm has institutional ownership of 71.70%, while insider ownership included 0.04%. Its price to sales ratio ended at 3.75. PFE attains analyst recommendation of 2.40 with week performance of 5.91%.

Harmonic Inc. (NASDAQ:HLIT) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with 8.08% to $5.35. A cybersecurity firm, Finjan Holdings, Inc. (NASDAQ:FNJN) reported that Eyal Harari has been designated as Chief Executive Officer of its wholly owned subsidiary, CybeRisk. Mr. Harari will be responsible for carrying out current contracts and ongoing business development for the risk advisory services business. Effective November 14, 2016, Eyal will replace Yoram Golandsky who is departing to lead an in-house security program for a financial institution.

“CybeRisk is an important subsidiary for Finjan, allowing us to leverage our 20-year history and deeply rooted knowledge in cybersecurity, for the benefit of the firm’s clients and consumers by creating awareness of cyber related risks,” stated Phil Hartstein, President and CEO of Finjan. “We firmly believe that people have to be part of any technology solution and we congratulate Eyal and look forward to continuing to build CybeRisk through his very capable leadership, we’d like to thank Yoram for his service and wish him well in his future endeavors.” The share price of HLIT attracts active investors, as stock price of week volatility recorded 7.82%. The stock is going forward to its 52-week low with 113.15% and lagging behind from its 52-week high price with -12.72%.

 

About Richard Avery

He is a capital projects manager and process design engineer at a large-cap company. He has renowned MBA degree. Before joining SWR, he was a freelance writer for renounce tech websites. He is currently studying for CFP exam. Interests: Tech stocks, Economic Markets, Blue-chips.

Check Also

x

United States Steel Corporation (NYSE:X) Could Be Looking At Restoring Up To 10K Jobs In U.S.

United States Steel Corporation (NYSE:X) [Trend Analysis] climbed reacts as active mover, shares an increase 4.28% …

Leave a Reply

Your email address will not be published. Required fields are marked *